Cover Image

An exploratory first‐in‐man study to investigate the pharmacokinetics and safety of liposomal dexamethasone at a 2‐ and 1‐week interval in patients with metastatic castration resistant prostate cancer

Abstract Dexamethasone has antitumor activity in metastatic castration resistant prostate cancer (mCRPC). We aimed to investigate intravenous liposome‐encapsulated dexamethasone disodium phosphate (liposomal dexamethasone) administration in mCRPC patients. In this exploratory first‐in‐man study, pat...

Full description

Saved in:

Bibliographic Details
Main Authors:	Josephina P. M. Vrouwe (Author), Ingrid M. C. Kamerling (Author), Michiel J. vanEsdonk (Author), Josbert M. Metselaar (Author), Frederik E. Stuurman (Author), Gabri van derPluijm (Author), Jacobus Burggraaf (Author), Susanne Osanto (Author)
Format:	Book
Published:	Wiley, 2021-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Oral Pheneticillin Absorption Test: An Accurate Method to Identify Patients with Inadequate Oral Pheneticillin Absorption
by: Anneke C. Dijkmans, et al.
Published: (2019)

Accelerating vaccine trial conduct in a pandemic with a hot spot‐based inclusion strategy using trial and epidemic simulation
by: Johan L. van derPlas, et al.
Published: (2021)

Recent Advances in Liposomal-Based Anti-Inflammatory Therapy
by: Carla M. A. van Alem, et al.
Published: (2021)

Development and characterization of liposomal formulation of bortezomib
by: Anil K. Deshantri, et al.
Published: (2019)

A novel sustained‐release cysteamine bitartrate formulation for the treatment of cystinosis: Pharmacokinetics and safety in healthy male volunteers
by: Cécile L. Berends, et al.
Published: (2021)

Population Pharmacokinetic/Pharmacodynamic Analysis of Nociceptive Pain Models Following an Oral Pregabalin Dose Administration to Healthy Subjects
by: Michiel J. vanEsdonk, et al.
Published: (2018)

Animal Castration
by: Liautard, Alexandre François Augustin, 1835-1918

Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization
by: Susan Hua, et al.
Published: (2018)

Item response theory in early phase clinical trials: Utilization of a reference model to analyze the Montgomery‐Åsberg Depression Rating Scale
by: Marije E. Otto, et al.
Published: (2023)

Quercetin Liposomal Nanoformulation for Ischemia and Reperfusion Injury Treatment
by: Margarida Ferreira-Silva, et al.
Published: (2022)

Prevalent levels of RSV serum neutralizing antibodies in healthy adults outside the RSV-season
by: Johan L. Van Der Plas, et al.
Published: (2020)

First-in-human study to assess the pharmacokinetics, tolerability, and safety of single-dose oxybutynin hydrochloride administered via a microprocessor-controlled intravaginal ring
by: Willem de Laat, et al.
Published: (2023)

Enzalutamide for the treatment of metastatic castration-resistant prostate cancer
by: Rodriguez-Vida A, et al.
Published: (2015)

Flexible nano-liposomes-based transdermal hydrogel for targeted delivery of dexamethasone for rheumatoid arthritis therapy
by: Yi-Pu Zhao, et al.
Published: (2022)

Sex‐dependent improvement in traumatic brain injury outcomes after liposomal delivery of dexamethasone in mice
by: Gherardo Baudo, et al.
Published: (2024)

Study protocol: DexaDays-2, hydrocortisone for treatment of dexamethasone-induced neurobehavioral side effects in pediatric leukemia patients: a double-blind placebo controlled randomized intervention study with cross-over design
by: A. M. van Hulst, et al.
Published: (2021)

Response and Resistance in Castration-Resistant Prostate Cancer
Published: (2020)

Acute Cold / Restraint Stress in Castrated Rats
by: Farideh Zafari Zangeneh, et al.
Published: (2008)

PK/PD modeling of 5‐hydroxytryptophan (5‐HTP) challenge test with cortisol measurement in serum and saliva
by: Zheng Guan, et al.
Published: (2020)

Fosfomycin: Pharmacological, Clinical and Future Perspectives
by: Anneke Corinne Dijkmans, et al.
Published: (2017)

Effect of Castration on Some Physiological Aspect in Rats: Effect of Testosterone Hormone
by: A. A. Hassan
Published: (2010)

Changes of electrocardiograms of animals with epinephrine heart damage in influences of stress and castration
by: R. Druziuk, et al.
Published: (2023)

Prediction of severe post-castration syndrome in women after surgical menopause
by: L.I. Butina, et al.
Published: (2022)

Apalutamide: Emerging Therapy for Non-Metastatic Castration-Resistant Prostate Cancer
by: Nora A. Alkhudair
Published: (2019)

Taxane resistance in castration-resistant prostate cancer: mechanisms and therapeutic strategies
by: Brandon Bumbaca, et al.
Published: (2018)

Advanced Therapeutic Options for Treatment of Metastatic Castration Resistant Prostatic Adenocarcinoma
by: Faiza Naseer, et al.
Published: (2021)

Dexamethasone and Dexamethasone Phosphate: Effect on DMPC Membrane Models
by: Candelaria Ines Cámara, et al.
Published: (2023)

Targeting mTOR Complex 2 in Castration-Resistant Prostate Cancer with Acquired Docetaxel Resistance
by: Huang Y, et al.
Published: (2022)

Evolving treatment approaches for the management of metastatic castration-resistant prostate cancer – role of radium-223
by: Mukherji D, et al.
Published: (2014)

Clinical and morphological features of post-castration syndrome in women after surgical menopause
by: L.I. Butina, et al.
Published: (2022)

Association of Monoamine Oxidase A with Tumor Burden and Castration Resistance in Prostate Cancer
by: Meenakshi Meenu, MBBS, MD, DM, et al.
Published: (2020)

HTA and innovative treatments evaluation: the case of metastatic castration-resistant prostate cancer
by: Bretoni A, et al.
Published: (2019)

Direct medical costs of using enzalutamide or abiraterone in chemotherapy-naïve patients with metastatic castration resistant prostate cancer
by: N. A. Avxentyev, et al.
Published: (2019)

Computational Modeling to Identify Drugs Targeting Metastatic Castration-Resistant Prostate Cancer Characterized by Heightened Glycolysis
by: Mei-Chi Su, et al.
Published: (2024)

Dexamethasone inhibits IL-9 production by human T cells
by: Cormont Francoise, et al.
Published: (2005)

Evaluation of Properties of Dexamethasone Eye Drops
by: Matušová D., et al.
Published: (2023)

Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancer
by: Channing J Paller, et al.
Published: (2011)

HTA and innovative treatments evaluation: the case of metastatic castration-resistant prostate cancer [Corrigendum]
by: Bretoni A, et al.
Published: (2019)

Targeting castration-resistant prostate cancer with a novel RORγ antagonist elaiophylin
by: Jianwei Zheng, et al.
Published: (2020)

Abiraterone acetate: oral androgen biosynthesis inhibitor for treatment of castration-resistant prostate cancer
by: Rosenberg JE, et al.
Published: (2012)